Ticker > Company >

Take share price

Take Ltd.

NSE: TAKE BSE: 532890 SECTOR: IT - Software  79.17 K   194   24

25.56
-1.34 (-4.98%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 25.98

Today's Low

₹ 25.56

52 Week High

₹ 49.9

52 Week Low

₹ 8.83

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

378.12 Cr.

Enterprise Value

374.9 Cr.

No. of Shares

14.79 Cr.

P/E

139.44

P/B

13.27

Face Value

₹ 1

Div. Yield

0 %

Book Value (TTM)

₹  1.93

CASH

3.22 Cr.

DEBT

0 Cr.

Promoter Holding

0 %

EPS (TTM)

₹  0.18

Sales Growth

-83.42%

ROE

16.72 %

ROCE

17.95%

Profit Growth

113.5 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Take Ltd.

Navitas

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-83.42%
3 Year-63.17%
5 Year-18.28%

Profit Growth

1 Year66.35%
3 Year22.85%
5 Year-255.24%

ROE%

1 Year16.72%
3 Year-6.56%
5 Year-4.29%

ROCE %

1 Year17.95%
3 Year-5.19%
5 Year-3.39%

Debt/Equity

0

Price to Cash Flow

-19.38

Interest Cover Ratio

14.5777

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2026 0.00 0.00
Dec 2025 0.00 0.00
Sep 2025 5.19 0.00
Jun 2025 53.34 0.00
Mar 2025 53.41 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The Company is trading at a PE of 139.44.
  • The Company is Virtually Debt Free.
  • The company has delivered average Profit Growth of 58.4527991883796% in last 3 years.
  • PEG ratio is 1.22863044473476%.

 Limitations

  • Company has a poor ROE (Return on Equity) track record: 3 Years’ ROE -6.55936666666667%.
  • The company has delivered poor Income growth of -63.1733346313651% over past 3 years.
  • The company has been maintaining a poor ROCE of -5.19213333333333% since last 3 years.
  • The company has been maintaining poor Dividend Payout ratio of 0% since last 3 years.
  • Promoter holding has decreased by 0% YoY.
  • Company has contingent liabilities of 13.195 Cr.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Net Sales 0 0 0 0 0
Total Expenditure 0.7 2.02 0.29 0.35 0.79
Operating Profit -0.7 -2.02 -0.29 -0.35 -0.79
Other Income 10.87 0.01 -0.04 1.46 5.19
Interest 0.2 0.15 0.15 0 0
Depreciation 0.01 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax 9.96 -2.17 -0.47 1.11 4.39
Tax 0 0 0.16 0 0
Profit After Tax 9.96 -2.17 -0.63 1.11 4.39
Adjusted EPS (Rs) 0.67 -0.15 -0.04 0.08 0.3

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 12.03 18 56.23 5.42 0.9
Total Expenditure 18.91 31.36 53.36 27.47 2.96
Operating Profit -6.87 -13.36 2.86 -22.05 -2.06
Other Income 1.5 17.27 9.07 0.87 12.98
Interest 0.36 0.3 0.68 0.74 0.75
Depreciation 1.57 1.23 1.11 0.72 0.05
Exceptional Items 0 -5.14 -5.44 -48.41 0
Profit Before Tax -7.3 -2.75 4.7 -71.05 10.13
Provision for Tax -1.28 2.37 0.41 4.01 0
Net Profit 7.79 -477.17 4.29 -207.25 -69.74
Adjusted EPS (Rs.) -0.41 -0.35 0.29 -5.07 0.68

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 14.79 14.79 14.79 14.79 14.79
Total Reserves 760.28 283.65 287.98 80.62 10.97
Borrowings 0 0 0 0 0
Other N/C liabilities 3.97 2.37 0.03 0.28 0
Current liabilities 4.83 10.96 15.36 23.48 5.9
Total Liabilities 783.88 311.77 318.16 119.18 31.66
Assets
Net Block 4.43 3.24 2.12 0.11 0.01
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 516.78 154.68 242.56 101.87 0
Loans & Advances 16.54 11.23 14.33 10.4 9.2
Other N/C Assets 0 37.91 0 0 0
Current Assets 246.12 104.7 59.15 6.81 22.45
Total Assets 783.88 311.77 318.16 119.18 31.66
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 6.52 -474.45 4.7 -203.24 -69.74
Adjustment -19.39 467.64 -1.45 201.66 67.72
Changes in Assets & Liabilities 10.33 39.57 28.08 -2.26 -17.77
Tax Paid -0.12 -0.19 -4.43 -0.64 0.29
Operating Cash Flow -2.66 32.58 26.89 -4.48 -19.51
Investing Cash Flow 13.42 -40.19 -22.37 -1.02 22.21
Financing Cash Flow -0.25 -1.11 -0.84 -0.23 -0.04
Net Cash Flow 10.51 -8.72 3.69 -5.73 2.66

Corporate Actions

Investors Details

PARTICULARS Sep 2024% Dec 2024% Mar 2025% Jun 2025% Sep 2025%
promoters 53.41 53.41 53.41 53.34 5.19
esyspro infotech limited - - - - 5.10
srinivasan h r 0.09 0.09 0.09 0.09 0.09
aakanksha management cons... - 0.42 0.42 0.35 -
take solutions pte limite... 52.90 52.90 52.90 52.90 -
aakanksha management cons... 0.42 - - - -
PARTICULARS Mar 2025% Jun 2025% Sep 2025% Dec 2025% Mar 2026%
investors 46.59 46.66 94.81 100.00 100.00
akarshika traders - - - 8.38 9.88
alia commosales - - - 2.24 3.07
avance ventures private l... - - 4.30 1.01 4.51
empower tradex private li... - - 4.90 1.46 2.78
investor education and pr... 0.14 - - 0.15 0.15
moonlight multitrade llp - - - 4.99 5.72
nikhilesh traders llp - - - 3.03 3.06
rukhmani garments llp - - - 5.37 5.70
sadbhav minerals private ... - - - 2.32 2.32
sarvagay textile - - - 4.78 4.81
the north consulting - - - 1.16 1.16
vaishali commosales llp - - - 4.69 5.06
whamia traders llp - - - 6.01 6.55
zuber trading llp - - - 4.72 4.77
llp 0.03 0.10 39.10 - -
investor education and pr... - 0.14 - - -

Annual Reports

Title Link
Title Link
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CARE RATINGS
Credit CARE
Credit INDIA RATINGS & RESEARCH
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q2FY21
Concall Q1FY21
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q3FY19
Presentation Q2FY21
Presentation Q1FY21

Company News

Take Solutions informs about scrutinizers report 18 Jun, 4:06 PM Take Solutions informs about board meeting 16 May, 12:34 PM Take Solutions touches roof on entering into longevity and Anti-ageing market in India 17 Apr, 2:26 PM Take Solutions enters into longevity and Anti-ageing market in India 17 Apr, 11:59 AM Take Solutions touches roof on launching Rs 5 crore innovation fund 6 Apr, 2:27 PM Take Solutions launches Rs 5 crore innovation fund 6 Apr, 2:17 PM Take Solution informs about press release 6 Apr, 12:37 PM Take Solutions touches roof on launching Take.Health 27 Mar, 11:36 AM Take Solutions launches Take.Health 25 Mar, 2:42 PM Take Solutions informs about press release 25 Mar, 11:34 AM Take Solutions inches up on incorporating wholly owned subsidiary 13 Mar, 11:13 AM Take Solutions touches roof on incorporating wholly owned subsidiary 12 Mar, 2:21 PM Take Solutions incorporates wholly owned subsidiary 12 Mar, 2:16 PM Take Solutions gains on planning to develop Unified AI Platform for healthcare ecosystem 17 Feb, 11:50 AM Take Solutions informs about press release 17 Feb, 11:28 AM Take Solutions to develop Unified AI Platform for healthcare ecosystem 17 Feb, 11:19 AM Take Solutions informs about press release 10 Feb, 3:37 PM Take Solutions soars on planning to set up ‘One Minute Clinic’ in India 10 Feb, 12:51 PM Take Solutions plans to set up ‘One Minute Clinic’ in India 10 Feb, 12:39 PM Take Solutions informs about disclosure 4 Dec, 12:30 PM Take Solutions - Quaterly Results 28 Oct, 12:00 AM Take Solutions informs about outcome of board meeting 27 Oct, 11:48 AM Take Solutions informs about outcome of board meeting 27 Oct, 11:45 AM Take Solutions informs about disclosure 4 Oct, 11:48 AM Take Solutions informs about disclosure 12 Aug, 1:15 PM Take Solutions informs about disclosure 5 Aug, 12:44 PM TAKE Solutions informs about scrutinizer report and voting results of EGM 1 Aug, 11:58 AM Take Solutions informs about outcome of board meeting 7 Jul, 5:22 PM Take Solutions informs about outcome of board meeting 7 Jul, 5:16 PM Take Solutions - Quaterly Results 7 Jul, 11:04 AM Take Solutions - Quaterly Results 7 Jul, 11:04 AM Take Solutions - Quaterly Results 7 Jul, 11:04 AM Take Solutions - Quaterly Results 12 Feb, 5:52 PM Take Solutions - Quaterly Results 12 Feb, 5:52 PM Take Solutions - Quaterly Results 22 Jan, 2:51 PM Take Solutions - Quaterly Results 22 Jan, 2:51 PM Take Solutions - Quaterly Results 22 Jan, 2:51 PM Take Solutions gets nod to divest 100% stake in Ecron Acunova 14 Sep, 12:32 PM Take Solutions - Quaterly Results 30 May, 2:54 PM TAKE Solutions informs about disclosure 18 May, 11:35 AM Take Solutions - Quaterly Results 13 Feb, 2:16 PM Take Solutions - Quaterly Results 13 Feb, 2:16 PM Take Solutions - Quaterly Results 13 Feb, 2:16 PM Take Solutions informs about board meeting 29 Jan, 4:28 PM Take Solutions informs about RTA certificate 9 Jan, 2:37 PM Take Solutions - Quaterly Results 8 Nov, 12:43 PM TAKE Solutions informs about newspaper publication 21 Sep, 12:15 PM Take Solutions - Quaterly Results 14 Aug, 2:13 PM Take Solutions - Quaterly Results 14 Aug, 2:13 PM Take Solutions - Quaterly Results 14 Aug, 2:13 PM

Take Stock Price Analysis and Quick Research Report. Is Take an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Take. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Take has a PE ratio of 137.9705400982 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Take has ROA of 13.4302% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Take has a Current ratio of 3.8075.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Take has a ROE of 16.7169%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Take has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: Take has reported revenue growth of -83.4163% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Take for the current financial year is -228.698553948832%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Take is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Take is Rs 0.1833. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Take in Ticker for free. Also, one can get the intrinsic value of Take by using Valuation Calculators, which are available with a Finology ONE subscription. 

Take FAQs

Q1. What is Take share price today?
Ans: The current share price of Take is Rs 25.29.

Q2. What is the market capitalisation of Take?
Ans: Take has a market capitalisation of Rs 374.125086 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Take?
Ans: The PE ratio of Take is 137.9705400982 and the P/B ratio of Take is 13.1328867424833, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Take share?
Ans: The 52-week high share price of Take is Rs 50.14, and the 52-week low share price of Take is Rs 8.88.

Q5. Does Take pay dividends?
Ans: Currently, Take does not pay dividends. Dividend yield of Take is around 0%.

Q6. What are the face value and book value of Take shares?
Ans: The face value of Take shares is Rs 1, while the book value per share of Take is around Rs 1.9257. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Take?
Ans: Take has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Take?
Ans: The ROE of Take is 16.7169% and ROCE of Take is 17.9481%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Take a good buy for the long term?
Ans: The Take long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Take undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Take appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Take’s financials?
Ans: You can review Take’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Take
X